Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects article

Clinical and Translational Gastroenterology

Volumn 9, Issue 5, 2018, Pages

  Bouter, K E C ^a   Bakker, G J ^a   Levin, E ^a   Hartstra, A V ^a   Kootte, R S ^a   Udayappan, S D ^a   Katiraei, S ^b   Bahler, L ^a   Gilijamse, P W ^a   Tremaroli, V ^c   Stahlman, M ^c   Holleman, F ^a   Van Riel, N A W ^a   Verberne, H J ^a   Romijn, J A ^a   Dallinga Thie, G M ^a   Serlie, M J ^a   Ackermans, M T ^a   Kemper, E M ^a   Willems Van Dijk, K ^b   Backhed, F ^c   Groen, A K ^a,d   Nieuwdorp, M ^a,c,e   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CHOLESTEROL; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SHORT CHAIN FATTY ACID; BILE ACID; BUTYRIC ACID DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT; VOLATILE FATTY ACID;

ARTICLE; BACTERIUM DETECTION; BACTEROIDES; BILE ACID METABOLISM; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLOSTRIDIALES; CONTROLLED STUDY; CORIOBACTERIACEAE; DRUG EFFICACY; DRUG FECES LEVEL; DRUG RESPONSE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LACHNOSPIRACEAE; LACTATE BLOOD LEVEL; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; ADULT; BLOOD; CHEMISTRY; DRUG EFFECT; ENERGY METABOLISM; FECES; INTESTINE FLORA; LIVER; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; UNDERWEIGHT; YOUNG ADULT;

ADIPOSE TISSUE, BROWN; ADMINISTRATION, ORAL; ADULT; BILE ACIDS AND SALTS; BUTYRATES; ENERGY METABOLISM; FATTY ACIDS, VOLATILE; FECES; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL MICROBIOME; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME; PILOT PROJECTS; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; THINNESS; YOUNG ADULT;

EID: 85047626228     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/s41424-018-0025-4     Document Type: Article

References (50)

1. Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of type 2 diabetes mellitus; present and future perspectives. Nat. Rev. Endocrinol. 8, 228-236 (2012).
2. Boyle, J. P. et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 8, 29 (2010).
3. Group, T. A. S. Long-Term effects of intensive glucose lowering on cardiovascular outcomes. N. Engl. J. Med. 364, 818-828 (2011).
4. Bouter, K. E. et al. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction. Gastroenterology 152, 1671-1678 (2017).
5. Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577-591 (2015).
6. Samuel, B. S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-Acid binding G protein-coupled receptor. Proc. Natl Acad. Sci. USA 105, 16767-16772 (2008).
7. Perry, R. J. et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature 534, 213-217 (2016).
8. Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517 (2009).
9. Li Z. et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut 2017. pii: gutjnl-2017-314050. https://doi.org/10.1136/gutjnl-2017-314050. [Epub ahead of print].
10. Ziȩtak, M. et al. Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metab. 23, 1216-1223 (2016).
11. Owen, B. M., Mangelsdorf, D. J. & Kliewer, S. A. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21. Trends Endocrinol. Metab. 26, 22-29 (2015).
12. Harms, M. & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 (2013).
13. Vijgen, G. H. et al. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J. Clin. Endocrinol. Metab. 97, E1229-E1233 (2012).
14. Hanssen, M. J. W. et al. Short-Term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat. Med. 21, 863-865 (2015).
15. Eckel, R. H. et al. The metabolic syndrome. Lancet 375, 181-183 (2010).
16. Sabatino, A. D. et al. Oral butyrate for mildly to moderately active Crohn's disease. Aliment. Pharmacol. Ther. 22, 789-794 (2005).
17. Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916.e7 (2012).
18. Steele, R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. N. Y. Acad. Sci. 82, 420-430 (1959).
19. Admiraal, W. M. et al. Cold-induced activity of brown adipose tissue in young lean men of South-Asian and European origin. Diabetologia 56, 2231-2237 (2013).
20. Alnouti, Y., Csanaky, I. L. & Klaassen, C. D. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J. Chromatogr. B 873, 209-217 (2008).
21. Hulzebos, C. V. et al. Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: Application to rodents and humans. J. Lipid Res. 42, 1923-1929 (2001).
22. Fuller, M. et al. The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 309, E840-E851 (2015).
23. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
24. Zhang, J. et al. PEAR: A fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30, 614-620 (2014).
25. DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069-5072 (2006).
26. Wang, Q. et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
27. Lozupone, C. & Knight, R. UniFrac: A new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228-8235 (2005).
28. Vazquez-Baeza, Y. et al. EMPeror: A tool for visualizing high-Throughput microbial community data. Gigascience 2, 16 (2013).
29. Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21, 494-504 (2011).
30. Anderson, M. J. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 26, 32-46 (2001).
31. Kootte, R. S. et al. Improvement of insulin sensitivity after lean donor fecal microbiota transplantation in subjects with metabolic syndrome is associated with baseline intestinal microbiota composition. Cell Metab. 26, 611-619 (2017).
32. Botschuijver, S. et al. Intestinal fungal dysbiosis associates with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology 153, 1026-1039 (2017).
33. Boets, E. et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: A stable isotope study. J. Physiol. 595, 541-555 (2017).
34. Wolever, T. M. S. et al. Effect of rectal infusion of short chain fatty acids in human subjects. Am. J. Gastroenterol. 84, 1027-1033 (1989).
35. Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744-1754 (2015).
36. van der Beek Christina, M. et al. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clin. Sci. 130, 2073-2082 (2016).
37. den Besten, G. et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G900-G910 (2013).
38. Macfarlane, S. & Macfarlane, G. T. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 62, 67-72 (2003).
39. den Besten, G. et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 64, 2398-2408 (2015).
40. Freeland, K. R. & Wolever, T. M. S. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α. Br. J. Nutr. 103, 460-466 (2009).
41. Venter, C. S., Vorster, H. H. & Cummings, J. H. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am. J. Gastroenterol. 85, 549-553 (1990).
42. Todesco, T. et al. Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. Am. J. Clin. Nutr. 54, 860-865 (1991).
43. Fernandes, J., Vogt, J. & Wolever, T. M. S. Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans. Eur. J. Clin. Nutr. 66, 1029-1034 (2012).
44. van Eunen, K. et al. Biochemical competition makes fatty-Acid β-oxidation vulnerable to substrate overload. PLoS Comput. Biol. 9, e1003186 (2013).
45. Wolever, T. M., Spadafora, P. & Eshuis, H. Interaction between colonic acetate and propionate in humans. Am. J. Clin. Nutr. 53, 681-687 (1991).
46. Elwood, J. C., Marcó, A. & Van Bruggen, J. T. Lipid Metabolism in the diabetic rat: IV. Metabolism of acetate, acetoacetate, butyrate, and mevalonate in vitro. J. Biol. Chem. 235, 573-577 (1960).
47. Sheng, L. et al. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. J. Pathol. 243, 431-441 (2017).
48. Belenguer, A. et al. Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol. Ecol. 77, 107-119 (2011).
49. Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29-41 (2017).
50. Canfora, E. E. et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: A randomized crossover trial. Sci. Rep. 7, 2360 (2017).